Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study.

OBJECTIVE To examine whether estrogen replacement therapy (ERT) prevents worsening of radiographic knee osteoarthritis (OA) in elderly women. METHODS A total of 551 women ages 63-91 years (mean age 71) in the Framingham Study were followed up from biennial examination 18 (1983-1985) to examination 22 (1992-1993). Data on postmenopausal ERT were obtained every 2 years. Subjects were classified into 3 groups according to their estrogen use at biennial examination 18: never users (n = 349), past users (n = 162), and current users (n = 40). Women received anteroposterior weight-bearing knee radiographs at examinations 18 and 22. Using the Kellgren and Lawrence criteria, global radiographic knee OA was assessed, (grade range 0-4) and individual radiographic features, such as osteophytes and joint space narrowing, were scored from 0 to 3. Worsening was defined as either development of radiographic OA that was not present at baseline (incident OA) or progression of baseline radiographic OA by > or =1 Kellgren and Lawrence grade (progressive OA). Potential confounding factors included age, body mass index, weight change, smoking, knee injury, physical activity level, and bone mineral density at the femoral neck. RESULTS During 8 years of followup, 17.4% of knee radiographic scores worsened by 1 grade and 5.8% by 2 or 3 grades among never users of ERT. Among current estrogen users, only 11.7% of knee radiographic scores worsened by 1 grade and none worsened by more than 1 grade. After adjusting for age and other potential confounding factors, the relative risk of incident radiographic knee OA in comparison with never users of estrogen was 0.8 (95% confidence interval [95% CI] 0.5-1.4) in past users and 0.4 (95% CI 0.1-3.0) in current users. Current use of estrogen also showed a trend toward decreased risk of progressive knee OA compared with never use (odds ratio [OR] 0.5, 95% CI 0.1-2.9). When both incident and progressive radiographic knee OA cases were combined, current ERT use had a 60% decreased risk compared with never use (OR 0.4, 95% CI 0.1-1.5). CONCLUSION This is the first prospective cohort study to examine the effects of ERT on radiographic knee OA. The results indicate that current use of ERT had a moderate, but not statistically significant, protective effect against worsening of radiographic knee OA among elderly white women. These findings corroborate those of cross-sectional studies and point further to a potential benefit of female hormones in OA.

[1]  M. Doherty,et al.  Is osteoarthritis in women affected by hormonal changes or smoking? , 1993, British journal of rheumatology.

[2]  W. Kannel,et al.  Estrogen use and radiographic osteoarthritis of the knee in women. The Framingham Osteoarthritis Study. , 1990, Arthritis and rheumatism.

[3]  A M Walker,et al.  Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. , 1995, Arthritis and rheumatism.

[4]  F. Wolfe,et al.  The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.

[5]  Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. , 1996, Archives of internal medicine.

[6]  E. Barrett-Connor.  Postmenopausal estrogen and the risk of breast cancer. , 1994, Annals of epidemiology.

[7]  R. Glynn,et al.  Musculoskeletal disease research: should we analyze the joint or the person? , 1996, The Journal of rheumatology.

[8]  P. Ross.  Osteoporosis. Frequency, consequences, and risk factors. , 1996, Archives of internal medicine.

[9]  D. Felson,et al.  The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. , 1995, Arthritis and rheumatism.

[10]  T. Spector,et al.  Is hormone replacement therapy protective for hand and knee osteoarthritis in women?: The Chingford study , 1997, Annals of the rheumatic diseases.

[11]  D. Felson.  The course of osteoarthritis and factors that affect it. , 1993, Rheumatic diseases clinics of North America.

[12]  Jh. Kellgren.  Radiological assessment of osteoarthritis , 1957 .

[13]  S. Cummings,et al.  Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. , 1996, Archives of internal medicine.

[14]  C. Cooper,et al.  Osteoarthritis of the hip and osteoporosis of the proximal femur. , 1991, Annals of the rheumatic diseases.

[15]  J. Kellgren,et al.  Generalized Osteoarthritis and Heberden's Nodes , 1952, British medical journal.

[16]  D. Felson,et al.  Estrogen Replacement Therapy and the Development of Osteoarthritis , 1996, Epidemiology.

[17]  R. Cecil,et al.  CLASSIFICATION AND TREATMENT OF CHRONIC ARTHRITIS , 1926 .

[18]  J. Kellgren,et al.  Radiological Assessment of Osteo-Arthrosis , 1957, Annals of the rheumatic diseases.

[19]  R. Glynn,et al.  Comparison of alternative regression models for paired binary data. , 1994, Statistics in Medicine.

[20]  Daniel Levy,et al.  Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. , 1993, Arthritis and rheumatism.

[21]  R. Stecher,et al.  Heberden's nodes; relationship of the menopause to degenerative joint disease of fingers. , 1949, Annals of the rheumatic diseases.

[22]  D. Felson,et al.  Epidemiology of hip and knee osteoarthritis. , 1988, Epidemiologic reviews.

[23]  The effect of postmenopausal estrogen therapy on bone density in elderly women. , 1993 .

[24]  L. Brinton,et al.  Estrogen replacement therapy and breast cancer risk. , 1993, Epidemiologic reviews.

[25]  J. Kelsey,et al.  Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. , 1989, The Journal of rheumatology.